Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors.
| Publicado en: | Targeted Oncology Vol. 19; no. 3; pp. 401 - 411 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
May2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178444217&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 178444217 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17762596 47DQ jtl: Targeted Oncology issn: 17762596 maglogo: N pubinfo: dt: May2024 vid: 19 iid: 3 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 178444217 176286829 10.1007/s11523-024-01047-y 178444217 ppf: 401 ppct: 10 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors. aug: au: Uchimoto, Taizo Tsuchida, Shuya Komura, Kazumasa Fukuokaya, Wataru Adachi, Takahiro Hirasawa, Yosuke Hashimoto, Takeshi Yoshizawa, Atsuhiko Saruta, Masanobu Hashimoto, Mamoru Higashio, Takuya Matsuda, Takuya Nishimura, Kazuki Tsujino, Takuya Nakamura, Ko Fukushima, Tatsuo Nishio, Kyosuke Yamamoto, Shutaro Iwatani, Kosuke Urabe, Fumihiko affil: https://ror.org/01y2kdt21 Department of Urology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, 569-8686, Takatsuki, Osaka, Japan sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|